Indian-made antibiotic for superbugs gets FDA approval

Indian-made antibiotic for superbugs gets FDA approval. This marks the first FDA nod for a novel antibiotic developed in India targeting drug-resistant infections. The approval opens up a $1.5 billion global market opportunity and validates India’s R&D capabilities in critical therapeutics. 📊 STOCKS: | 🏢 SECTOR: Pharma | #HIGHIMPACT #FDA